April Bailey-Maletta, DPM
Foot Surgery · Lindenhurst, NYNPI 1316106438
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,494 of the $3,694 with a category attached, or 67.5%. 18 manufacturers reported payments, led by Polaris Technology Solutions LLC at 32.8% of the total. Reporting peaked in 2022 at $1,351 and has fallen 76.7% since, to $314 in 2025.
Across 81 payments — averaging $45.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Polaris Technology Solutions LLC$1K
- Smith+Nephew$911
- Kerecis Limited$434
- Organogenesis Inc.$252
- Misonix Inc$180
- Nevro Corp.$137
- plus $567 from 12 others
What the payments were for
- Food & beverage$2,49468%
- Education$1,20032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Polaris Technology Solutions LLC | 2 | $1,213 |
| Smith+Nephew | 42 | $911 |
| Kerecis Limited | 3 | $434 |
| Organogenesis Inc. | 7 | $252 |
| Misonix Inc | 2 | $180 |
| Nevro Corp. | 1 | $137 |
| Orthofix Medical, Inc. | 6 | $135 |
| Integra Lifesciences Corporation | 5 | $98 |
| Bioventus LLC | 3 | $69 |
| Avita Medical Americas, LLC | 1 | $40 |
| Zimmer Biomet | 1 | $37 |
| Treace Medical Concepts, Inc. | 1 | $36 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $34 |
| Merck | 1 | $33 |
| Solventum Corporation | 1 | $33 |
| Tactile Systems Technology Inc | 1 | $22 |
| Stryker | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$1,001
- Kerecis Omega3 GraftGuide$334
- Kerecis Omega3 Marigen$334
- Affinity$140
- Senza$137
- Stravix$128
How this compares
$3,694 in reported general payments places this provider in the 85th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 172 | $121,647 |
| JubliaEfinaconazole | 54 | $76,394 |
| Diclofenac Sodium | 29 | $2,761 |
| Ammonium Lactate | 85 | $1,117 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 25 | $1,114 |
| Betamethasone Dipropionate | 12 | $722 |
| Clotrimazole | 29 | $661 |
| Mupirocin | 92 | $643 |
| CiclopiroxCiclopirox Olamine | 16 | $528 |
| Minocycline Hcl | 20 | $229 |
| Levofloxacin | 12 | $146 |
| Meloxicam | 42 | $145 |
| Doxycycline Hyclate | 13 | $112 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $89 |
| Cefadroxil | 13 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $34 | $76,39454 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 294 foot surgery providers in New York.
Other foot surgery in Lindenhurst
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Corrine RenneFranklin Square$20K
- Charles MorelliMamaroneck$18K
- Evan BrethBrooklyn$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.